Heparanase activity in alveolar and embryonal rhabdomyosarcoma: Implications for tumor invasion

BMC Cancer

Volumn 9, Issue , 2009, Pages 304-

  Masola, Valentina ^a   Maran, Claudio ^a   Tassone, Evelyne ^a   Zin, Angelica ^b   Rosolen, Angelo ^b   Onisto, Maurizio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARANASE; MATRIGEL; MESSENGER RNA; PROTEOHEPARAN SULFATE; SHORT HAIRPIN RNA;

ADOLESCENT; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYONAL RHABDOMYOSARCOMA; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RHABDOMYOSARCOMA; RNA INTERFERENCE; SKELETAL MUSCLE; SUPERNATANT; TUMOR BIOPSY; WESTERN BLOTTING;

ADOLESCENT; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCURONIDASE; HUMANS; INFANT; MALE; NEOPLASM INVASIVENESS; RHABDOMYOSARCOMA, ALVEOLAR;

EID: 70349849375     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-304     Document Type: Article

References (26)

1. Merlino G, Helman LJ. Rhabdomyosarcoma - working out the pathways. Oncogene 1999, 18(38):5340-5348. 10.1038/sj.onc.1203038, 10498887.
2. Breitfeld PP, Meyer WH. Rhabdomyosarcoma: new windows of opportunity. Oncologist 2005, 10(7):518-527. 10.1634/theoncologist.10-7-518, 16079319.
3. Wijnaendts LC, Linden JC, van Unnik AJ, Delemarre JF, Voute PA, Meijer CJ. Histopathological classification of childhood rhabdomyosarcomas: relationship with clinical parameters and prognosis. Hum Pathol 1994, 25(9):900-907. 10.1016/0046-8177(94)90009-4, 8088765.
4. Duffy MJ, McGowan PM, Gallagher WM. Cancer invasion and metastasis: changing views. J Pathol 2008, 214(3):283-293. 10.1002/path.2282, 18095256.
5. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001, 411(6835):375-379. 10.1038/35077241, 11357145.
6. Stetler-Stevenson WG, Yu AE. Proteases in invasion: matrix metalloproteinases. Semin Cancer Biol 2001, 11(2):143-152. 10.1006/scbi.2000.0365, 11322833.
7. Yung S, Chan TM. Glycosaminoglycans and proteoglycans: overlooked entities?. Perit Dial Int 2007, 27(Suppl 2):S104-9.
8. Sanderson RD, Yang Y, Kelly T, MacLeod V, Dai Y, Theus A. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies. J Cell Biochem 2005, 96(5):897-905. 10.1002/jcb.20602, 16149080.
9. Parish CR, Freeman C, Hulett MD. Heparanase: a key enzyme involved in cell invasion. Biochim Biophys Acta 2001, 1471(3):M99-108.
10. Vlodavsky I, Goldshmidt O, Zcharia E, Metzger S, Chajek-Shaul T, Atzmon R, Guatta-Rangini Z, Friedmann Y. Molecular properties and involvement of heparanase in cancer progression and normal development. Biochimie 2001, 83(8):831-839. 10.1016/S0300-9084(01)01318-9, 11530216.
11. Vlodavsky I, Ilan N, Naggi A, Casu B. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr Pharm Des 2007, 13(20):2057-2073. 10.2174/138161207781039742, 17627539.
12. Ilan N, Elkin M, Vlodavsky I. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol 2006, 38(12):2018-2039. 10.1016/j.biocel.2006.06.004, 16901744.
13. Miao HQ, Liu H, Navarro E, Kussie P, Zhu Z. Development of heparanase inhibitors for anti-cancer therapy. Curr Med Chem 2006, 13(18):2101-2111. 10.2174/092986706777935230, 16918340.
14. Simizu S, Ishida K, Osada H. Heparanase as a molecular target of cancer chemotherapy. Cancer Sci 2004, 95(7):553-558. 10.1111/j.1349-7006.2004.tb02485.x, 15245589.
15. Shafat I, Barak AB, Postovsky S, Elhasid R, Ilan N, Vlodavsky I, Arush MW. Heparanase levels are elevated in the plasma of pediatric cancer patients and correlate with response to anticancer treatment. Neoplasia 2007, 9(11):909-916. 10.1593/neo.07673, 2077882, 18030359.
16. Kubista M, Andrade JM, Bengtsson M, Forootan A, Jonak J, Lind K, Sindelka R, Sjoback R, Sjogreen B, Strombom L, Stahlberg A, Zoric N. The real-time polymerase chain reaction. Mol Aspects Med 2006, 27(2-3):95-125. 10.1016/j.mam.2005.12.007, 16460794.
17. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987, 47(12):3239-3245.
18. Xu X, Quiros RM, Maxhimer JB, Jiang P, Marcinek R, Ain KB, Platt JL, Shen J, Gattuso P, Prinz RA. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis. Clin Cancer Res 2003, 9(16 Pt 1):5968-5979.
19. Onisto M, Slongo ML, Gregnanin L, Gastaldi T, Carli M, Rosolen A. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines. Int J Oncol 2005, 27(3):791-798.
20. McKenzie EA. Heparanase: a target for drug discovery in cancer and inflammation. Br J Pharmacol 2007, 151(1):1-14. 10.1038/sj.bjp.0707182, 2012981, 17339837.
21. Hulett MD, Hornby JR, Ohms SJ, Zuegg J, Freeman C, Gready JE, Parish CR. Identification of active-site residues of the pro-metastatic endoglycosidase heparanase. Biochemistry 2000, 39(51):15659-15667. 10.1021/bi002080p, 11123890.
22. Zetser A, Levy-Adam F, Kaplan V, Gingis-Velitski S, Bashenko Y, Schubert S, Flugelman MY, Vlodavsky I, Ilan N. Processing and activation of latent heparanase occurs in lysosomes. J Cell Sci 2004, 117(Pt 11):2249-2258. 10.1242/jcs.01068, 15126626.
23. Nadav L, Eldor A, Yacoby-Zeevi O, Zamir E, Pecker I, Ilan N, Geiger B, Vlodavsky I, Katz BZ. Activation, processing and trafficking of extracellular heparanase by primary human fibroblasts. J Cell Sci 2002, 115(Pt 10):2179-2187.
24. Zcharia E, Jia J, Zhang X, Baraz L, Lindahl U, Peretz T, Vlodavsky I, Li JP. Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases. PLoS ONE 2009, 4(4):e5181. 10.1371/journal.pone.0005181, 2664924, 19360105.
25. Quiros RM, Rao G, Plate J, Harris JE, Brunn GJ, Platt JL, Gattuso P, Prinz RA, Xu X. Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival. Cancer 2006, 106(3):532-540. 10.1002/cncr.21648, 16388520.
26. Vlodavsky I, Friedmann Y, Elkin M, Aingorn H, Atzmon R, Ishai-Michaeli R, Bitan M, Pappo O, Peretz T, Michal I, Spector L, Pecker I. Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nat Med 1999, 5(7):793-802. 10.1038/10518, 10395325.